M 320 β-L-Cytidine |
|
|
MORpure™ Delivered ≥ 98% pure with dated HPLC UV chromatogram
|
|
| Solid | |
| Screw cap v-vial | 1 mg $215 |
| M.W. 243.22 | 5 mg $565 |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1692 β-L-Cytidine, [3H]- |
|
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 5 Ci(185 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 243.22 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 142 Cytidine, [14C(U)]- |
|
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Ethanol:water (2:98) solution, 100 μCi/ml | |
| > 390 mCi(14.43 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial | |
| M.W. 243.22 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 2014 Cytidine, [cytosine-14C(U)]- |
|
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 100 μCi/ml | |
| > 180 mCi(6.66 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 243.22 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 128 Cytidine, [2-14C]- Click here for Typical Certificate of Analysis |
|
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Aqueous solution, 100 μCi/ml | 50 μCi (1.85 MBq) $3970 |
| > 45 mCi(1.665 GBq)/mmol | 100 μCi (3.7 MBq) $4450 |
| NextGen V-Vial | |
| M.W. 243.22 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 615 Cytidine, [5-3H(N)]- |
|
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Aqueous solution, 1 mCi/ml | 250 μCi (9.25 MBq) $1970 |
| > 20 Ci(740 GBq)/mmol | 1 mCi (37 MBq) $2385 |
| NextGen V-Vial | 5 mCi (185 MBq) $3145 |
| M.W. 243.22 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1966 Cytidine, [6-3H]- |
|
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 1.0 mCi/ml | |
| > 20 Ci(740 GBq)/mmol | 50 μCi (1.85 MBq) $1160 |
| NextGen V-Vial | 250 μCi (9.25 MBq) $1970 |
| M.W. 243.22 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
